AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20817383 — intervention group
Group type: EXPERIMENTAL
Intervention: BASICS (Brief Alcohol Screening and Intervention for College Students)
Number of subjects: 1275
Study 20817383 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 1275
Study 17991638 — intervention group
Group type: COMPARATOR
Intervention: Diet intervention
Number of subjects: 188
Study 17991638 — intervention group
Group type: COMPARATOR
Intervention: Exercise intervention
Number of subjects: 188
Study 17991638 — intervention group
Group type: COMPARATOR
Intervention: Combined diet and exercise intervention
Number of subjects: 188
Study 17991638 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 188
Study 15655825 — intervention group
Group type: EXPERIMENTAL
Intervention: HCC vaccine group
Number of subjects: 60
Study 15655825 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 11910388 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase I cardiac rehabilitation intervention (experimental group)
Number of subjects: 60
Study 11910388 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention (comparison group)
Number of subjects: 60
Study 9791816 — intervention group
Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK) using an erodible disc and axicon lens
Number of subjects: 21
Study 7535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (200 mg orally)
Number of subjects: 18
Study 7535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (120 mg orally)
Number of subjects: 18
Study 7535669 — intervention group
Group type: EXPERIMENTAL
Intervention: GH releasing hormone (GHRH) 1‐44 (80 micrograms i.v.)
Number of subjects: 18
Study 7535669 — intervention group
Group type: COMPARATOR
Intervention: Diabetic subjects
Number of subjects: 18
Study 7535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose
Number of subjects: 18
Study 2540285 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids
Number of subjects: 312
Study 2540285 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 312
Study 15894 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 50 mg progesterone and 3 mg oestradiol benzoate in oil
Number of subjects: 300
Study 15894 — intervention group
Group type: COMPARATOR
Intervention: No hormonal injection (Control)
Number of subjects: 300
Study 29428088 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral cobalamin (0.4–1.2 mg hydroxycobalamin according to body weight)
Number of subjects: 53
Study 29428088 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cobalamin tablets (0.25–1.0 mg cyanocobalamin daily according to body weight)
Number of subjects: 53
Study 27616175 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent group (6 times/week or more)
Number of subjects: 32
Study 27616175 — intervention group
Group type: COMPARATOR
Intervention: Intermittent group (2 times/week)
Number of subjects: 32
Study 24980426 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg before surgery followed by 200 mg TID for 4 days
Number of subjects: 212
Study 24980426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 21920646 — intervention group
Group type: EXPERIMENTAL
Intervention: Group health education programme
Number of subjects: 100
Study 20397455 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and herbal medicine
Number of subjects: 60
Study 20397455 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C and Vitamin E (Control)
Number of subjects: 60
Study 18473407 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day therapy (omeprazole 20 mg bid, clarithromycin 500 mg bid, amoxicillin 1 g bid)
Number of subjects: 136
Study 18473407 — intervention group
Group type: COMPARATOR
Intervention: 10-day therapy (same medication as group 1)
Number of subjects: 136
Study 18473407 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day therapy
Number of subjects: 136
Study 18473407 — intervention group
Group type: COMPARATOR
Intervention: 10-day therapy
Number of subjects: 136
Study 16169320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 27
Study 16169320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 12809972 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased copayments in 1995 and 1997 for antidepressants, anxiolytics, and sedatives
Number of subjects: 0
Study 12809972 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased copayments in 1997 for antidepressants
Number of subjects: 0
Study 11219596 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical M-mode echocardiography
Number of subjects: 124
Study 9208628 — intervention group
Group type: EXPERIMENTAL
Intervention: Interfon-Alpha (1 million units per day for 5-7 days)
Number of subjects: 31
Study 9208628 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 31
Study 1407968 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg/day
Number of subjects: 3711
Study 1407968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3711
Study 1407968 — intervention group
Group type: EXPERIMENTAL
Intervention: Early full scatter photocoagulation
Number of subjects: 3711
Study 1407968 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mild scatter photocoagulation
Number of subjects: 3711
Study 1407968 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferral of photocoagulation
Number of subjects: 3711
Study 1407968 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (combined endpoint)
Number of subjects: 3711
Study 1407968 — intervention group
Group type: EXPERIMENTAL
Intervention: Before vitrectomy
Number of subjects: 3711
Study 1407968 — intervention group
Group type: EXPERIMENTAL
Intervention: One year after vitrectomy
Number of subjects: 3711
Study 2860268 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide 12 mg daily (n = 14)
Number of subjects: 49
Study 2860268 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide 6 mg daily (n = 18)
Number of subjects: 49
Study 2860268 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers (pindolol, metipranolol, atenolol, n = 17)
Number of subjects: 49
Study 31965906 — intervention group
Group type: EXPERIMENTAL
Intervention: Second half-course (SHC) tourniquet application
Number of subjects: 102
Study 31965906 — intervention group
Group type: COMPARATOR
Intervention: Full-course (FC) tourniquet application
Number of subjects: 102
Study 29927750 — intervention group
Group type: EXPERIMENTAL
Intervention: Normocapnic hyperpnea training (group 1)
Number of subjects: 22
Study 29927750 — intervention group
Group type: COMPARATOR
Intervention: Sham maneuvers (group 2)
Number of subjects: 22
Study 27514766 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (1000 mg/d from flaxseed oil)
Number of subjects: 60
Study 27514766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25522399 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (6 weeks)
Number of subjects: 19
Study 22857780 — intervention group
Group type: EXPERIMENTAL
Intervention: Avanafil 100 mg
Number of subjects: 390
Study 22857780 — intervention group
Group type: EXPERIMENTAL
Intervention: Avanafil 200 mg
Number of subjects: 390
Study 22857780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study 19855976 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate only (25 mg, four times/week)
Number of subjects: 60
Study 19855976 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin only (0.4 mg once daily)
Number of subjects: 60
Study 19855976 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sildenafil citrate and tamsulosin
Number of subjects: 60
Study 18721577 — intervention group
Group type: EXPERIMENTAL
Intervention: iNO + Mil (inhalation of nitric oxide plus milrinone)
Number of subjects: 46
Study 18721577 — intervention group
Group type: COMPARATOR
Intervention: iNO (inhalation of nitric oxide)
Number of subjects: 46
Study 18721577 — intervention group
Group type: COMPARATOR
Intervention: Mil (milrinone)
Number of subjects: 46
Study 15985065 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning group (5-year-old children and adults)
Number of subjects: 2
Study 15985065 — intervention group
Group type: COMPARATOR
Intervention: Other groups (not learning the category distinction)
Number of subjects: 2
Study 12464165 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy with Alternaria extract (mean accumulated dose: 280,000 PNU)
Number of subjects: 39
Study 12464165 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy with Alternaria extract
Number of subjects: 39
Study 12464165 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment (control group)
Number of subjects: 39
Study 10597050 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 62
Study 10597050 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training (Charcot‐Marie‐Tooth group)
Number of subjects: 62
Study 10597050 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training (after 24 weeks)
Number of subjects: 62
Study 8739163 — intervention group
Group type: EXPERIMENTAL
Intervention: Root surfaces smoothed after plaque and calculus removal using Gracey curettes; evaluated at 3 and 6 months post-surgery
Number of subjects: 13
Study 8739163 — intervention group
Group type: COMPARATOR
Intervention: Root surfaces roughened using a coarse diamond stone after traditional root planing; evaluated at 3 and 6 months post-surgery
Number of subjects: 13
Study 1868680 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose phenobarbital incorporated into methadone medication
Number of subjects: 20
Study 1868680 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory measurements of phenobarbital and methadone
Number of subjects: 20
Study 7092752 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic-feedback training (Group I)
Number of subjects: 18
Study 7092752 — intervention group
Group type: COMPARATOR
Intervention: Sham training in an alternative cognitive task (Group II)
Number of subjects: 18
Study 7092752 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Group III)
Number of subjects: 18
Study 31192911 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning surgery (Group A)
Number of subjects: 44
Study 31192911 — intervention group
Group type: COMPARATOR
Intervention: Afternoon surgery (Group B)
Number of subjects: 44
Study 28138179 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental 3 mg/kg intravenously followed by an additional dose of 1 mg/kg to achieve Ramsay sedation score of 4
Number of subjects: 120
Study 28138179 — intervention group
Group type: COMPARATOR
Intervention: Ketofol (1:1 mixture of ketamine 10 mg/mL and propofol 10 mg/mL) at a dose of 0.5 mg/kg at 1 minute intervals to achieve Ramsay sedation score of 4
Number of subjects: 120
Study 26230151 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed during the list study phase
Number of subjects: 0
Study 26230151 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed during the memory test phase
Number of subjects: 0
Study 26230151 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed during both phases
Number of subjects: 0
Study 26230151 — intervention group
Group type: COMPARATOR
Intervention: Unprimed problems
Number of subjects: 0
Study 25349008 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (0.5 mg/kg orally)
Number of subjects: 134
Study 25349008 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (10 mg/kg)
Number of subjects: 134
Study 21797891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alcohol infusion (50 mg%) for 3 hours
Number of subjects: 48
Study 21797891 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion for 3 hours
Number of subjects: 48
Study 19020525 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia treatment
Number of subjects: 0
Study 19020525 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study 17550348 — intervention group
Group type: EXPERIMENTAL
Intervention: HUT with occlusion (pressure cuff at 250 mmHg)
Number of subjects: 22
Study 17550348 — intervention group
Group type: EXPERIMENTAL
Intervention: HUT without occlusion
Number of subjects: 22
Study 15827099 — intervention group
Group type: EXPERIMENTAL
Intervention: octreotide-LAR (10 mg, n = 10 subjects)
Number of subjects: 20
Study 15827099 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 10 subjects)
Number of subjects: 20
Study 12072674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous erythromycin (250 mg/6 hrs)
Number of subjects: 40
Study 12072674 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenous 5% dextrose, 50 mL/6 hrs)
Number of subjects: 40
Study 12072674 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 40
Study 12072674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9576385 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR assay for Hib DNA in blood culture supernatants
Number of subjects: 1575
Study 9576385 — intervention group
Group type: COMPARATOR
Intervention: Conventional culture techniques
Number of subjects: 1575
Study 7827545 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine (as quinine sulphate)
Number of subjects: 107
Study 7827545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 1325513 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril 12.5 mg
Number of subjects: 16
Study 1325513 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril 25 mg
Number of subjects: 16
Study 1325513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 1325513 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril (both doses)
Number of subjects: 16
Study 6594021 — intervention group
Group type: EXPERIMENTAL
Intervention: Duraphat
Number of subjects: 381
Study 6594021 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 381
Study 30556959 — intervention group
Group type: EXPERIMENTAL
Intervention: Miridesap 10 mg IV infusion
Number of subjects: 0
Study 30556959 — intervention group
Group type: EXPERIMENTAL
Intervention: Miridesap 20 mg IV infusion
Number of subjects: 0
Study 30556959 — intervention group
Group type: EXPERIMENTAL
Intervention: Miridesap 40 mg IV infusion
Number of subjects: 0
Study 30556959 — intervention group
Group type: EXPERIMENTAL
Intervention: Miridesap 20 mg/h IV infusion (15-hour duration)
Number of subjects: 0
Study 30556959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28926864 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (Synergo ®)
Number of subjects: 0
Study 28926864 — intervention group
Group type: EXPERIMENTAL
Intervention: Conductive Mitomycin C therapy (Combat ® and Unithermia ® devices)
Number of subjects: 0
Study 26708124 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (8 to 15 mg, titrated to weight)
Number of subjects: 12
Study 26708124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 26708124 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 12
Study 24644106 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 30-120 mg once daily
Number of subjects: 291
Study 24644106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study 22305835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor (30 μg/Kg bolus plus 4 μg/Kg/min infusion)
Number of subjects: 13049
Study 22305835 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose)
Number of subjects: 13049
Study 20300081 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 213
Study 20300081 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study 18052563 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 345
Study 16116318 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (LGG)
Number of subjects: 75
Study 16116318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 12408205 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative behavioral intervention based on net-present value economic theory
Number of subjects: 0
Study 12408205 — intervention group
Group type: COMPARATOR
Intervention: Standard risk-factor approach in control group
Number of subjects: 0
Study 9237705 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (125 mg, 250 mg, 500 mg daily for 14 days)
Number of subjects: 36
Study 9237705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 9237705 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (125 mg daily)
Number of subjects: 36
Study 8216067 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglyconate suture (Maxon)
Number of subjects: 56
Study 8216067 — intervention group
Group type: COMPARATOR
Intervention: Other currently available sutures
Number of subjects: 56
Study 2448657 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (3 g/m2 iv weekly with leukovorin rescue)
Number of subjects: 166
Study 2448657 — intervention group
Group type: COMPARATOR
Intervention: Low-dose methotrexate (30 mg/m2 orally weekly without rescue)
Number of subjects: 166
Study 2448657 — intervention group
Group type: COMPARATOR
Intervention: CAVP therapy
Number of subjects: 166
Study 2448657 — intervention group
Group type: COMPARATOR
Intervention: Patients with 'B' symptoms
Number of subjects: 166
Study 30354411 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter Ablation (CA)
Number of subjects: 52
Study 30354411 — intervention group
Group type: COMPARATOR
Intervention: Surgical MIPI
Number of subjects: 52
Study 27567756 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of extended-release theophylline
Number of subjects: 18
Study 27567756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 24925330 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing post-conditioning (PPC) plus percutaneous coronary intervention (PCI)
Number of subjects: 60
Study 24925330 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 60
Study 22379743 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexpanthenol nasal spray
Number of subjects: 50
Study 22379743 — intervention group
Group type: COMPARATOR
Intervention: Normal saline nasal spray
Number of subjects: 50
Study 20150523 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg)
Number of subjects: 8
Study 20150523 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin (20 mg)
Number of subjects: 8
Study 18191847 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (P) only as luteal support (200 mg bid starting the following night after oocyte retrieval)
Number of subjects: 176
Study 18191847 — intervention group
Group type: COMPARATOR
Intervention: E(2) and P combined (E(2) patches 100 microg/day twice per week starting on the day of embryo transfer with P)
Number of subjects: 176
Study 16157525 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (0.74 mg/kg of body weight) used for coronary flow reserve assessment
Number of subjects: 48
Study 16157525 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of risk factors (0-3)
Number of subjects: 48
Study 16157525 — intervention group
Group type: EXPERIMENTAL
Intervention: Degree of coronary artery stenosis
Number of subjects: 48
Study 14503903 — intervention group
Group type: COMPARATOR
Intervention: Sling treatment for shoulder dislocation
Number of subjects: 3
Study 14503903 — intervention group
Group type: EXPERIMENTAL
Intervention: External rotation treatment (splint or pillow)
Number of subjects: 3
Study 10825403 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted venous occlusion plethysmography
Number of subjects: 215
Study 10825403 — intervention group
Group type: COMPARATOR
Intervention: Standard radiology
Number of subjects: 215
Study 8863556 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg fluoxetine daily for 1 week and 40 mg daily afterward (group 1)
Number of subjects: 17
Study 8863556 — intervention group
Group type: COMPARATOR
Intervention: 1 capsule placebo daily for 1 week and 2 capsules daily afterward (group 2)
Number of subjects: 17
Study 1407240 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg/day calcium supplement
Number of subjects: 42
Study 1407240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 3903158 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine
Number of subjects: 17
Study 3903158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31061380 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-transplantation care in the first year
Number of subjects: 306
Study 31061380 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-transplantation care after the first year
Number of subjects: 306
Study 28929567 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 4004
Study 28929567 — intervention group
Group type: COMPARATOR
Intervention: Control (no BCG vaccination)
Number of subjects: 4004
Study 28929567 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination in children with atopic predisposition
Number of subjects: 4004
Study 28929567 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination in children without atopic predisposition
Number of subjects: 4004
Study 26721340 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular-flavored dentifrice
Number of subjects: 0
Study 26721340 — intervention group
Group type: EXPERIMENTAL
Intervention: Specially-flavored dentifrice
Number of subjects: 0
Study 24050647 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Shortening Manoeuvre (MSM)
Number of subjects: 60
Study 24050647 — intervention group
Group type: COMPARATOR
Intervention: Traditional physiotherapeutic technique (scapulothoracic gliding)
Number of subjects: 60
Study 24050647 — intervention group
Group type: COMPARATOR
Intervention: Simple traction (added mass applied without fast accelerations)
Number of subjects: 60